1
Home
Companies

Ocata Therapeutics

Ocata Therapeutics
Leadership team

Paul Wotton (Founder)

Products/ Services
Biotechnology, Health Care, Therapeutics
Number of Employees
0 - 50
Headquarters
Marlborough, Massachusetts, United States
Established
1994
Company Registration
SEC CIK number: 0001140098
Traded as
NASDAQ:OCAT
Social Media
URL
www.ocata.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Ocata Therapeutics, Inc. is a biotechnology company, which focuses on developing and commercializing pharmaceutical products that improve the treatment of ophthalmic conditions and other medical disorders. It offers a platform of regenerative medicine technology with a particular focus on treatments made from pluripotent stem cells. The company also provides disease specific programs that address target back of the eye diseases. It serves customers in the United States and internationally.
History

Ocata Therapeutics was founded in 2008 and is headquartered in Alameda, California. The company has facilities in Singapore, the United Kingdom, and India. In 2013, Ocata Therapeutics acquired Advanced Cell Technology, Inc., a stem cell biotechnology company, and Stem Cells Inc., a stem cell therapy development company. In 2014, the company announced a strategic collaboration with the California Institute for Biomedical Research. In 2015, Ocata Therapeutics acquired intellectual property and developed an exclusive license from Neuralstem, Inc., a stem cell therapy development company.

Mission
We strive to develop safe and effective cell therapies for a broad range of therapeutic areas by leveraging our proprietary technology platform.
Vision
Our vision is to build a sustainable and innovative biotechnology company that is focused on developing life-changing treatments and cures for unmet medical needs.
Key Team

Paul Wotton (Founder)

Recognition and Awards
Ocata Therapeutics has been recognized by the American Association for the Advancement of Science, the Elsevier Global Stem Cell Summit, and numerous other organizations for its outstanding contributions to the field of regenerative medicine.
References

https://in.investing.com/equities/advanced-cell-tech

https://www.crunchbase.com/organization/ocata-therapeutics

www.ocata.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Ocata Therapeutics
Leadership team

Paul Wotton (Founder)

Products/ Services
Biotechnology, Health Care, Therapeutics
Number of Employees
0 - 50
Headquarters
Marlborough, Massachusetts, United States
Established
1994
Company Registration
SEC CIK number: 0001140098
Traded as
NASDAQ:OCAT
Social Media
URL
www.ocata.com